Skip to main content
. 2021 Jan 7;23(2):302–309. doi: 10.1002/ejhf.2082

Figure 2.

EJHF-2082-FIG-0002-c

(A) Primary endpoint: comparison of change in left ventricular ejection fraction (LVEF) 6 months after therapy. (B) Comparison of change in left ventricular end‐diastolic volume (LVEDV) 6 months after therapy. IVIG, intravenous immunoglobulin.